Suzuki,
I think investors are concerned about a potential capital raising to fund the new trial in the US in the absence of any strategic partner. I think the market is somewhat spooked by that issue. And the market is unclear of what the plans are going forward regarding potential sales and revenue of the oncisil device post CE Mark.
Investor call, page-35
Add OSL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.7¢ |
Change
0.000(0.00%) |
Mkt cap ! $49.19M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 66 | 28870585 | 0.7¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.8¢ | 15151 | 1 |
View Market Depth
| Last trade - 09.38am 19/11/2024 (20 minute delay) ? |
| OSL (ASX) Chart |
Day chart unavailable
